RELX is a global provider of data analytics and decision tools, serving professional and business customers in over 180 countries through four segments: Risk, Scientific Technical & Medical (STM), Legal, and Exhibitions. The core business model is built around aggregating proprietary, hard-to-replicate data sets — sourced from public records, licensed suppliers, and contributory databases — and layering analytics and AI on top to deliver insights customers embed into their own workflows. Risk (~36% of revenue) serves financial institutions, insurers, and government agencies with tools for financial crime compliance, identity verification, and insurance underwriting analytics; over 90% of divisional revenue comes from machine-to-machine integrations. STM (~28% of revenue) operates primarily through Elsevier, publishing peer-reviewed journals and offering research discovery and analytics tools like Scopus and ScienceDirect to academic institutions and healthcare professionals. Legal (~19% of revenue) serves law firms and corporate legal departments through LexisNexis, combining verified legal content with AI-enabled research tools including Lexis+ AI and the agentic assistant Protege. Exhibitions (~13% of revenue) operates trade shows and is more transactional in nature. Print, now only ~4% of revenue, is in managed decline. Revenue is predominantly subscription-based under multi-year contracts, creating strong visibility. Growth is driven by new product launches, customer adoption of higher-value platforms, and volume. RELX pursues bolt-on M&A to add data or technology capabilities, and actively prunes non-core assets.